CN1175835C - Medicine for treating cervical vertebra disease - Google Patents
Medicine for treating cervical vertebra disease Download PDFInfo
- Publication number
- CN1175835C CN1175835C CNB001293230A CN00129323A CN1175835C CN 1175835 C CN1175835 C CN 1175835C CN B001293230 A CNB001293230 A CN B001293230A CN 00129323 A CN00129323 A CN 00129323A CN 1175835 C CN1175835 C CN 1175835C
- Authority
- CN
- China
- Prior art keywords
- radix
- processed
- medicine
- cervical spondylosis
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses a traditional Chinese medicine prescription for treating cervical spondylosis, which is prepared from lucid ganoderma of mount tai, milkvetch root, kudzuvine root, fructus viticis, radix ligustici sinensis, angelica, hemlock parsley, honeysuckle stem, phellodendron bark, white mustard seed, pinellia tuber, tuckahoe, clematis root, cassia twig, hematite, wild ginger, suberect spatholobus, safflower, red sage root, fleeceflower root, white peony alba, processed myrrh, stir-fried fankincense, synthetic bovine bezoar, chamois horn powder, notoginseng, raw licorice and cordyceps according to the theory of determining the treatment based on the differentiation of symptoms and signs of traditional Chinese medical science for cervical spondylosis and the prescription principles of traditional Chinese medicines. The present invention has better therapeutic and mitigative effects on symptoms of pain, vertigo, nausea, sleepless, palpitation, tinnitus, weakness, lassitude in the loin and the knees, etc. which are caused by cervical spondylosis.
Description
The present invention relates to medicine, specifically, is a kind of Chinese prescription for the treatment of cervical spondylosis.
Cervical spondylosis is a kind of commonly encountered diseases of orthopaedics, is that its cardinal symptom is a pain owing to due to the degeneration of cervical vertebra, be main pathological change with hyperosteogeny often, and can be with performances such as dizzy, nauseating, insomnia, cardiopalmus, tinnitus, weak, soreness of the waist and knees.The treatment means of doctor trained in Western medicine mostly is and adopts nonsteroidal anti-inflammatory analgetic thing (as aspirin, ibuprofen, indometacin etc.) at present, but owing to there is significantly untoward reaction, usually brings very big mental burden to the patient; Though physical therapy and acupuncture and moxibustion therapy untoward reaction are less, its late result still seldom arrives certainly; On the market common as " Unguentum Moschus et Os Tigris " though easy to use since some raw material (as Os Tigris) thus scarcity its curative effect is had a greatly reduced quality.
Purpose of the present invention aims to provide a kind of Chinese prescription that can either play fine treatment or relief of symptoms effect to osteoarthritis.
Solution of the present invention is according to understanding and the determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs principle of the traditional Chinese medical science to cervical spondylosis, processes according to traditional Chinese medical science prescription and preparation principle.
Chinese herbal medicine of the present invention is formed (consumption is a weight portion, and the back is together) by following component:
The Mount Taishan red ganoderma: 30～80, the Radix Astragali: 100～200, Radix Puerariae: 100～200; graceful Fructus Vitics Simplicifoliae: 40～90, Rhizoma Ligustici: 40～80, Radix Angelicae Sinensis: 50～95; Rhizoma Chuanxiong: 45～80, Caulis Lonicerae: 120～210, Cortex Phellodendri: 50～95; Semen Sinapis Albae: 30～75, the Rhizoma Pinelliae: 30～120, Poria: 50～200; Radix Clematidis: 50～120; Ramulus Cinnamomi: 30～80, Haematitum: 100～210, Herba Asari: 15～40; Caulis Spatholobi: 50～150; Flos Carthami: 50～100, Radix Salviae Miltiorrhizae: 50～150, Radix Polygoni Multiflori: 50～150; the Radix Paeoniae Alba: 50～80; Myrrha (processed): 50～160, Olibanum (processed): 50～160, artificial Calculus Bovis: 3～5; Cornu Saigae Tataricae powder: 5～12; Radix Notoginseng: 6～15, Radix Glycyrrhizae: 10～15, Cordyceps: 5～12.
Optimum ratio of the present invention is:
The Mount Taishan red ganoderma: 35～60, the Radix Astragali: 120～180, Radix Puerariae: 120～180; graceful Fructus Vitics Simplicifoliae: 40～60, Rhizoma Ligustici: 40～60, Radix Angelicae Sinensis: 60～75; Rhizoma Chuanxiong: 50～70, Caulis Lonicerae: 150～180, Cortex Phellodendri: 55～70; Semen Sinapis Albae: 35～50, the Rhizoma Pinelliae: 40～80, Poria: 80～150; Radix Clematidis: 60～100; Ramulus Cinnamomi: 40～70, Haematitum: 150～200, Herba Asari: 20～30; Caulis Spatholobi: 100～135; Flos Carthami: 50～80, Radix Salviae Miltiorrhizae: 100～135, Radix Polygoni Multiflori: 100～135; the Radix Paeoniae Alba: 55～70; Myrrha (processed): 50～100, Olibanum (processed): 50～100, artificial Calculus Bovis: 3～4; Cornu Saigae Tataricae powder: 6～10; Radix Notoginseng: 8～15, Radix Glycyrrhizae: 10～15, Cordyceps: 5～10.
Optimal proportion of the present invention is:
The Mount Taishan red ganoderma: 40, the Radix Astragali: 150, Radix Puerariae: 150, graceful Fructus Vitics Simplicifoliae: 45, Rhizoma Ligustici: 40; Radix Angelicae Sinensis: 65, Rhizoma Chuanxiong: 60, Caulis Lonicerae: 160, Cortex Phellodendri: 60, Semen Sinapis Albae: 40; the Rhizoma Pinelliae: 45, Poria: 100, Radix Clematidis: 75, Ramulus Cinnamomi: 50, Haematitum: 180; Herba Asari: 25, Caulis Spatholobi: 120, Flos Carthami: 60, Radix Salviae Miltiorrhizae: 120, Radix Polygoni Multiflori: 120; the Radix Paeoniae Alba: 60, Myrrha (processed): 60, Olibanum (processed): 60, artificial Calculus Bovis: 3; Cornu Saigae Tataricae powder: 8, Radix Notoginseng: 12, Radix Glycyrrhizae: 12, Cordyceps: 6.
With Cordyceps, Radix Notoginseng porphyrize in the above medicine, except that Calculus Bovis, add 12000 parts in water, soaked 1～2 hour.Slow fire is fried in shallow oil three times altogether to the back 15 minutes extracting juice that seethe with excitement afterwards, three 12000 parts of extracting juice altogether.With the Calculus Bovis porphyrize, pour in the above juice after water flies and stir evenly, decoct, conventional sterilization and sealing in the bottle of can packing into.
Also can make fine powder, incapsulate behind 400 mesh sieves excessively, every capsule 0.25 gram behind the above pharmaceutical drying.
Each component compatibility among the present invention uses the effect that can play QI invigorating the lucid yang sending up, regulating the stomach and sending down the abnormal ascending QI, the kidney tonifying of enriching blood, sensible refreshment, the strong ridge of clever neck, removing obstruction in the collateral to relieve pain, thereby symptoms such as the pain that causes for cervical spondylosis and dizzy, nauseating, insomnia, cardiopalmus, tinnitus, weak, soreness of the waist and knees have treatment or mitigation preferably, and the present invention does not have obvious toxic-side effects, and the patient comparatively is easy to accept.
Most preferred embodiment of the present invention is as follows:
The Mount Taishan red ganoderma: 40, the Radix Astragali: 150, Radix Puerariae: 150, graceful Fructus Vitics Simplicifoliae: 45, Rhizoma Ligustici: 40; Radix Angelicae Sinensis: 65, Rhizoma Chuanxiong: 60, Caulis Lonicerae: 160, Cortex Phellodendri: 60, Semen Sinapis Albae: 40; the Rhizoma Pinelliae: 45, Poria: 100, Radix Clematidis: 75, Ramulus Cinnamomi: 50, Haematitum: 180; Herba Asari: 25, Caulis Spatholobi: 120, Flos Carthami: 60, Radix Salviae Miltiorrhizae: 120, Radix Polygoni Multiflori: 120; the Radix Paeoniae Alba: 60, Myrrha (processed): 60, Olibanum (processed): 60, artificial Calculus Bovis: 3; Cornu Saigae Tataricae powder: 8, Radix Notoginseng: 12, Radix Glycyrrhizae: 12, Cordyceps: 6.
The patient heavier to the state of an illness takes decoct earlier, every day secondary, each 200 milliliters, took continuously 5～10 days, take capsule again, every day secondary, each 4～6,10 is a course of treatment, takes 2～3 courses of treatment continuously.
The patient lighter to the state of an illness can directly take capsule, every day secondary, each 4～6,10 is a course of treatment, takes 2～3 courses of treatment continuously.
Claims (3)
1. medicine for the treatment of cervical spondylosis, it is characterized in that: described medicine is to be made up of following component according to weight portion:
Mount Taishan red ganoderma 30～80; the Radix Astragali 100～200; Radix Puerariae 100～200; graceful Fructus Vitics Simplicifoliae 40～90; Rhizoma Ligustici 40～80; Radix Angelicae Sinensis 50～95; Rhizoma Chuanxiong 45～80; Caulis Lonicerae 120～210; Cortex Phellodendri 50～95; Semen Sinapis Albae 30～75; the Rhizoma Pinelliae 30～120; Poria 50～200; Radix Clematidis 50～120; Ramulus Cinnamomi 30～80; Haematitum 100～210; Herba Asari 15～40; Caulis Spatholobi 50～150; Flos Carthami 50～100; Radix Salviae Miltiorrhizae 50～150; Radix Polygoni Multiflori 50～150; the Radix Paeoniae Alba 50～80; Myrrha (processed) 50～160; Olibanum (processed) 50～160; the artificial Calculus Bovis 3～5; Cornu Saigae Tataricae powder 5～12; Radix Notoginseng 6～15; Radix Glycyrrhizae 10～15; Cordyceps 5～12.
2. the medicine of treatment cervical spondylosis according to claim 1 is characterized in that: described medicine is to be made up of following component according to weight portion:
Mount Taishan red ganoderma 35～60; the Radix Astragali 120～180; Radix Puerariae 120～180; graceful Fructus Vitics Simplicifoliae 40～60; Rhizoma Ligustici 40～60; Radix Angelicae Sinensis 60～75; Rhizoma Chuanxiong 50～70; Caulis Lonicerae 150～180; Cortex Phellodendri 55～70; Semen Sinapis Albae 35～50; the Rhizoma Pinelliae 40～80; Poria 80～150; Radix Clematidis 60～100; Ramulus Cinnamomi 40～70; Haematitum 150～200; Herba Asari 20～30; Caulis Spatholobi 100～135; Flos Carthami 50～80; Radix Salviae Miltiorrhizae 100～135; Radix Polygoni Multiflori 100～135; the Radix Paeoniae Alba 55～70; Myrrha (processed) 50～100; Olibanum (processed) 50～100; the artificial Calculus Bovis 3～4; Cornu Saigae Tataricae powder 6～10; Radix Notoginseng 8～15; Radix Glycyrrhizae 10～15; Cordyceps 5～10.
3. the medicine of treatment cervical spondylosis according to claim 1 is characterized in that: described medicine is to be made up of following component according to weight portion:
Mount Taishan red ganoderma 40, the Radix Astragali 150, Radix Puerariae 150, graceful Fructus Vitics Simplicifoliae 45, Rhizoma Ligustici 40, Radix Angelicae Sinensis 65, Rhizoma Chuanxiong 60, Caulis Lonicerae 160, Cortex Phellodendri 60, Semen Sinapis Albae 40, the Rhizoma Pinelliae 45, Poria 100, Radix Clematidis 75, Ramulus Cinnamomi 50, Haematitum 180, Herba Asari 25, Caulis Spatholobi 120, Flos Carthami 60, Radix Salviae Miltiorrhizae 120, Radix Polygoni Multiflori 120, the Radix Paeoniae Alba 60, Myrrha (processed) 60, Olibanum (processed) 60, artificial Calculus Bovis 3, Cornu Saigae Tataricae powder 8, Radix Notoginseng 12, Radix Glycyrrhizae 12, Cordyceps 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001293230A CN1175835C (en) | 2000-11-14 | 2000-11-14 | Medicine for treating cervical vertebra disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001293230A CN1175835C (en) | 2000-11-14 | 2000-11-14 | Medicine for treating cervical vertebra disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1352957A CN1352957A (en) | 2002-06-12 |
| CN1175835C true CN1175835C (en) | 2004-11-17 |
Family
ID=4593403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001293230A Expired - Fee Related CN1175835C (en) | 2000-11-14 | 2000-11-14 | Medicine for treating cervical vertebra disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1175835C (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100427122C (en) * | 2005-06-06 | 2008-10-22 | 柳英远 | Medicine for treating protrasion of the lumbar intervertebral disci |
| CN100349594C (en) * | 2005-08-30 | 2007-11-21 | 程玉峰 | Obstruction dredging wine |
| CN101843708B (en) * | 2009-10-28 | 2011-08-24 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating cervical spondylosis |
| CN101843729B (en) * | 2009-11-04 | 2011-08-24 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating cervical spondylosis |
| CN103157019A (en) * | 2011-12-13 | 2013-06-19 | 刘桐言 | A traditional Chinese medicine formula for treatment of cervical spondylosis and a preparation method for the traditional Chinese medicine |
| CN102743703B (en) * | 2012-07-18 | 2013-12-18 | 山东益宝生物制品有限公司 | Medicament for treating cervical spondylosis and preparation method thereof |
| CN102988639B (en) * | 2012-10-27 | 2014-03-26 | 王勤 | Medicament for treating cervical spondylosis and preparation method of medicament |
| CN106237109A (en) * | 2016-08-24 | 2016-12-21 | 路明芳 | A kind of Chinese medicine treating cervical spondylosis |
| CN106491794A (en) * | 2016-12-13 | 2017-03-15 | 重庆德盈汽车零部件有限公司 | A kind of pharmaceutical composition and preparation method thereof, headrest |
-
2000
- 2000-11-14 CN CNB001293230A patent/CN1175835C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1352957A (en) | 2002-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103393879B (en) | Traditional Chinese medicine composition for treating liver and kidney deficiency | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN1298346C (en) | Dynamic medicine for channels and collaterals and blood vessel | |
| CN1139396C (en) | Life essence-filling, marrow-benefitting and kidney invigorating Chinese medicine preparation | |
| CN1286518C (en) | Chinese medicinal prescription for treating gastropathy | |
| CN102512632B (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN104667047A (en) | Traditional Chinese medicine liquor for treating diabetic feet | |
| CN1175835C (en) | Medicine for treating cervical vertebra disease | |
| CN104288424A (en) | Traditional Chinese materia medica preparation for treating interventional post-operation deep venous thrombosis and preparation method thereof | |
| CN103599496A (en) | Traditional Chinese medicine for treatment of chronic gastritis | |
| CN103041200B (en) | Traditional Chinese medicine composition for treating cerebral hemorrhage | |
| CN102988616B (en) | Chinese medicinal composition for treating anemia | |
| CN102416145B (en) | Chinese medicinal composition for treating menstrual disorder | |
| CN104225426A (en) | Chinese medicine for treating cerebral arteriosclerosis and preparation method thereof | |
| CN1159037C (en) | Medicine for treating apoplexy | |
| CN103211980A (en) | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess | |
| CN102357227A (en) | Chinese medicinal composition for treating qi stagnation and blood stasis amenorrhea | |
| CN102406765B (en) | Traditional Chinese medicine composition for treating acne | |
| CN101040960A (en) | Medicine for treating hepatitis | |
| CN103550549A (en) | Traditional Chinese medicine (TCM) composition for treating deficiency of heart-yin | |
| CN1285378C (en) | Nourishing wine for regulating human body balance function | |
| CN1283302C (en) | Medicament for treating rheumatoid arthritis and artjritis pauperum | |
| CN102600414B (en) | Chinese medicinal composition for treating cervical spondylosis | |
| CN105963450A (en) | Traditional Chinese medicine composition for treating dizziness and faintness | |
| CN111437330A (en) | Composition for regulating menstruation and relieving pain, dispersible tablet, concentrated soft extract and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |